Integrated target-based and phenotypic screening approaches for the identification of anti-tubercular agents that bind to the mycobacterial adenylating enzyme MbtA

Lindsay Ferguson, Geoff Wells, Sanjib Bhakta, James Johnson, Junitta Guzman, Tanya Parish, Robin A. Prentice, Federico Brucoli

Research output: Contribution to journalArticle

Abstract

Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the host. MbtA is the adenylating enzyme that catalyses the initial reaction of mycobactin biosynthesis and is solely expressed by mycobacteria. A 3200‐member library comprised of lead‐like, structurally diverse compounds was screened against M. tuberculosis for whole‐cell inhibitory activity. A set of 846 compounds that inhibited the tubercle bacilli growth were then tested for their ability to bind to MbtA using a fluorescence‐based thermal shift assay and NMR‐based Water‐LOGSY and saturation transfer difference (STD) experiments. We identified an attractive hit molecule, 5‐hydroxyindol‐3‐ethylamino‐(2‐nitro‐4‐trifluoromethyl)benzene (5), that bound with high affinity to MbtA and produced a MIC90 value of 13 μm. The ligand was docked into the MbtA crystal structure and displayed an excellent fit within the MbtA active pocket, adopting a binding mode different from that of the established MbtA inhibitor Sal‐AMS.
Original languageEnglish
Pages (from-to)1735-1741
Number of pages7
JournalChemMedChem
Volume14
Issue number19
Early online date27 Aug 2019
DOIs
Publication statusPublished - 4 Oct 2019

Keywords

  • Compound screening
  • Iron homeostasis
  • Mycobactins
  • NMR spectroscopy
  • Siderophores
  • Tuberculosis

Cite this